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OBJECTIVE: The passive cycle ergometer aims to prevent hypotrophy and improve muscle strength, with a
consequent reduction in hospitalization time in the intensive care unit and functional improvement. However,
its effects on oxidative stress and immune system parameters remain unknown. The aim of this study is to
analyze the effects of a passive cycle ergometer on the immune system and oxidative stress in critical patients.
METHODS: This paper describes a randomized controlled trial in a sample of 19 patients of both genders who
were on mechanical ventilation and hospitalized in the intensive care unit of the Hospital Agamenom
Magalha˜es. The patients were divided into two groups: one group underwent cycle ergometer passive exercise
for 30 cycles/min on the lower limbs for 20 minutes; the other group did not undergo any therapeutic
intervention during the study and served as the control group. A total of 20 ml of blood was analysed, in which
nitric oxide levels and some specific inflammatory cytokines (tumour necrosis factor alpha (TNF-a), interferon
gamma (IFN-g) and interleukins 6 (IL-6) and 10 (IL-10)) were evaluated before and after the study protocol.
RESULTS: Regarding the demographic and clinical variables, the groups were homogeneous in the early phases
of the study. The nitric oxide analysis revealed a reduction in nitric oxide variation in stimulated cells (p=0.0021)
and those stimulated (p=0.0076) after passive cycle ergometer use compared to the control group. No dif-
ferences in the evaluated inflammatory cytokines were observed between the two groups.
CONCLUSION: We can conclude that the passive cycle ergometer promoted reduced levels of nitric oxide,
showing beneficial effects on oxidative stress reduction. As assessed by inflammatory cytokines, the treatment
was not associated with changes in the immune system. However, further research in a larger population is
necessary for more conclusive results.
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’ INTRODUCTION
Critical patients who require mechanical ventilation (MV)
for an extended time period due to underlying disease and
adverse effects of drugs undergo an important functional loss.
The long immobilization period causes severe osteomyoarti-
cular system dysfunction and is increasingly frequent in these
patients (1,2). These irregularities create muscle function losses
ranging from a daily decline of 1.3 force to 3 - 10% during an
entire week of immobility (3).
Immobilization in bed and increased MV dependence may
adversely affect several organs and systems, leading to the
following consequences: muscle contractures; functional loss;
reduced maximal oxygen uptake (VO2 Max); muscle weak-
ness in the intensive care unit (ICU); deep venous thrombosis;
pressure ulcers; pneumonia; atelectasis; bone demineraliza-
tion; and changes in the emotional state such as anxiety,
apathy and depression (4).
Muscle weakness, which is common in critical patients, is
associated with an inflammatory dysregulation that appears
to contribute to myopathy. The mechanism for muscle decay
due to immobility has not yet been completely clarified.
Two molecular interactions are involved: oxidative stress and
selected proinflammatory cytokines. It is believed that thisDOI: 10.6061/clinics/2017(03)03
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synergy between oxidative stress, inflammatory cytokines and
inactivity causes or accelerates muscular atrophy (5,6).
Many studies have been developed with the objective
of preventing the deleterious effects of ICU-acquired paresis
or to minimize it, as an alternative therapy. Amongst the
recommended procedures are passive exercises and/or
activities, daily sedation suspension and reduced infusion of
drugs such as neuromuscular blockers and corticosteroids, the
maintenance of homeostasis of electrolytes and nutritional
intake (7).
The effects of physical exercise in critical patients for the
prevention of atrophy and muscle strength improvement with
a consequent reduction in hospitalization time in intensive
care and functional improvement have rapidly expanded in
recent years. However, changes in oxidative stress and immune
system parameters of these patients are not well defined and
require further study, thus justifying the aim of this research of
improving our understanding of the effect of isolated passive
cycle ergometry use in critical patients. Therefore, this study
analyses the oxidative stress and the immune system para-
meters after passive cycle ergometry use on lower limbs in
critical patients.
’ MATERIALS AND METHODS
This was a randomized controlled trial, with a sample
consisting of 19 MV patients of both genders hospitalized in
the ICU of Hospital Agamenom Magalhães (HAM) who met
the inclusion criteria. The study protocol was conducted in
the ICU of HAM, but the blood analysis was performed
in the laboratory of Immunology Keizo Asami (LIKA) at
the Universidade Federal de Pernambuco. This study was
approved by the Ethics and Research Committee (ERC) of
the hospital under CAAE number 04563612.5.0000.5197, and
all legal guardians of the patients signed informed consent
(TFCC).
The patients who underwent MV presented a good
cardiovascular reserve, demonstrated by less than 20% heart
rate (HR) variability, systolic blood pressure (SBP) less than
200 mmHg or greater than 90 mmHg, normal electrocardio-
gram (no evidence of acute myocardial infarction or arrhythmia)
and a good respiratory reserve, demonstrated by a peripheral
oxygen saturation (SpO2) greater than 90% and an inspired
fraction of oxygen (FiO2) less than 60%, without signs of
respiratory distress and a respiratory rate (RR) less than
25 ipm. Other clinical parameters necessary for inclusion in
this study were as follows: stable haemoglobin of 47 g/dL,
stable platelet count of 420,000 cells/mm3, white blood cell
count of 4,300 - 10,800 cells/mm3, body temperature o38oC
and blood glucose levels of 3.5 – 20 mmol/L. Other
parameters included an acceptable patient appearance, pain,
fatigue, shortness of breath and emotional status; a stable
conscious state, no other neurological contraindications, no
orthopaedic contraindications, no recent SSG / flap to lower
limbs or trunk, medically stable without vasoactive drugs
and/or minimal doses, excessive weight able to be safely
managed, no attachments that contraindicated mobilisation,
safe environment, appropriate staffing and expertise and
patient consent.
Patients who presented with hemodynamic instability,
the inability to walk without assistance before acute disease
in the ICU, under 21 years old, pregnant women, patients
with a body mass index (BMI) greater than 35 Kg/m2 (2),
neuromuscular disease or vascular disease, cerebrovascular
accident history, non-consolidated fractures or any osteo-
myoarticular limitation that precludes cycle ergometry use
were excluded from the study.
After being recruited to the study, the participants were
evaluated through medical records, demographic informa-
tion, medical history and diagnosis. Data on neuromuscular
blockers, sedatives and vasoactive drugs were also collected.
When this initial review of all patients was completed,
they were submitted to blood collection by central venous
access, both before and 1 hour after the study protocol
finalization. For each patient, a total of 20 ml of blood was
collected with vacuum tubes (Vacutainers) DIPOTASSIUM
EDTA (Juiz de Fora, Minas Gerais, Brazil) to evaluate the
oxidative stress and immune system parameters as indicated
by the cytokines tumour necrosis factor alpha (TNF-a), inter-
feron gamma (IFN-g) and interleukins 6 (IL-6) and 10 (IL-10).
Oxidative stress was evaluated with EDTA in monocytes
obtained from the peripheral blood. The blood was diluted
at a ratio of 1:2:00 pm with sterile PBS culture medium at
a room temperature of 22 to 25o C (10 ml+10 ml blood in
PBS). A total of 10 ml of histopaque (1077-SIGMA) was
added to 20 ml of the suspension, and all contents were
centrifuged for 30 minutes at 1,600 rpm (25o C). Soon after,
the plasma was aspirated, and the layer formed by the cells
was collected (PBMC) and transferred to another test tube.
The same amount of aspirated PBS was added and centri-
fuged for 15 minutes under the same conditions as before.
The supernatant was decanted and sedimented in 1 ml of
RPMI 1640 medium containing 3% bovine foetal serum and
antibiotics (100 U/ml penicillin and 100 mg/ml streptomy-
cin). The suspension calculation was performed in a Neu-
bauer chamber assuming the rate of adding a suspension of
cells and trypan blue dye in a 1:10 dilution. This dye was
used for cell calculation and for assessing their viability.
It was standardized to a concentration of 1106 cells for
each 1 ml of culture medium from the measurements.
Nitric oxide (NO) production in cultured monocytes
treated with Escherichia coli lipopolysaccharide (LPS)
In each group, the concentration was adjusted to 1106
cells in 1 ml of culture medium to each well. The cells were
treated at a dose of 10 mg/ml of LPS for 24 hours. The NO
evaluation release was performed using the GRIESS method.
First, 50 ml of GRIESS reagent (1 g of sulphanilamide, Sigma
9251; 0.1 g of N- (naphthyl) ethylenediamine dihydrochloride,
Sigma 5889; 2.5 ml of phosphoric acid PA; and qsp 100 ml of
distilled water) was added. Then, the plate was incubated for
10 minutes in the dark. The reading was performed at 540 nm
in an ELISA reader (Dynatech MR 5000). The sensitivity test
threshold was 1.56 mM.
Analysis of immune system parameters by quantifi-
cation of IL-6, IL-10, TNF-a and IFN-g
Serum levels of IL-6, IL-10, TNF-a and IFN-g were
determined using ELISA commercials kits for IL-6, Il-10,
TNF-a and IFN-g (BioSource s, Nivelles, Belgium, Europe)
according to the manufacturer’ instructions. In this tech-
nique, a specific monoclonal antibody is adsorbed to the
plate. After the serum sample addition of the mediator to be
dosed, during incubation, the molecules of antigens settle to
the antibodies adsorbed to the plate. Through washing, any
non-fixed materials are eliminated. Next, new antibodies
with specificity for an antigenic determinant connected to the
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plate are added, resulting in the complex Bc-Ag-Ac-enzyme
(sandwich technique). A second wash is performed for the
removal of unlinked antibodies. Then, a substrate is added
that has the property of assuming a different coloration when
in contact with the enzyme; this colour is proportional to the
amount of mediator present in the sample (antigen). The
reading is obtained in a plate reader (Bio-Rad, Tokyo, Japan)
at 450 nm and compared to a standard curve obtained with
known concentrations of recombinant mediators.
Study protocol
The study population was divided into two groups: the
control group, consisting of 10 patients who were without
any type of therapeutic intervention at the moment when
they were submitted to the study protocol, and the inter-
vention group, consisting of 9 patients who were submitted
to passive cycle ergometry on their lower limbs with the
speed adjusted at 30 cycles per minute for 20 minutes, by
a cycle ergometer (Flex Motor with sensor; Cajumoro;
Braganc¸a Paulista, Sao Paulo, Brazil). Figure 1 demonstrates
the protocol in the lower limbs. The participation in one of
the two groups in this study was randomly determined by
Microsoft Office Excel 2007.
All results and demographic characteristics were assessed
using GraphPad Prism 4 software and Microsoft Office
Excel 2007. The presentation of the measured variables was
performed through tables and figures. The median and the
percentile (25-75%) were used to present continuous vari-
ables, whereas categorical data were presented using absolute
and relative frequencies.
To test the normality assumption of the variables in the
study, the Shapiro-Wilk test was used. The comparative analysis
between two groups was performed using the Mann-Whitney
test, and the Wilcoxon test was used to compare the same
group. Fisher’s exact test was used to evaluate the differences
between the proportions. The relationship between variables
was assessed using the Spearman correlation (non-normal
distribution). All findings were considered at a 5% signifi-
cance level.
’ RESULTS
During the study period, from December 2013 to February
2016, a total of 465 patients with various diseases were admit-
ted to the general ICU, of whom 439 individuals met the exclu-
sion criteria of the study. Only 26 patients were randomized
into two groups; amongst these, only 19 patients finished their
analysis, distributed as follows: control group (n=10) and
exercise group (n=9) (Figure 2).
Table 1 presents the median and percentile (25 - 75%) of
the demographic and clinical variables of each of the two
groups: control and cycle ergometer. There were no differ-
ences between the two groups regarding age, height, weight,
BMI, APACHEII, water balance (BH) in the last 12:00 am,
sedation scale of RASS, MV, hospitalization time in ICU,
hemoglucotest (HGT), respiratory system compliance (Cst),
respiratory system resistance (Rsr), HR, SpO2, SBP, diastolic
blood pressure (DBP), temperature (T) and ICU mortality,
demonstrating the homogeneity between the groups.
Figures 3a and 3b represent the results obtained from the
NO analysis of stimulated monocytes (positive controls) and
unstimulated (negative control) collected before and after the
study protocol from both groups. These figures revealed a
reduction in NO variation in the production of stimulated
monocytes (p=0.0021) and unstimulated (p=0.0076) after
passive cycle ergometry use compared to the control group.
Table 2 shows the median and percentile (25 - 75%) values
for the cytokines, TNF-a, IFN-g, IL-6 and IL-10, analysed
before and after the study protocol for each group, in which
there were no significant changes in cytokines compared to
the moments before and after for the two groups.
Correlations were made between cytokines (TNF-a, IL-6,
IL-10 and IFN-g) and NO concentration in the stimulated
cells, positive control (C+) and negative control (C-) without
any significant difference at p40.05.
’ DISCUSSION
There is no evidence in the literature that describes the
effects of a passive cycle ergometer on oxidative stress and
immune system parameters in critical patients. However,
several other benefits of this intervention have been widely
observed, particularly regarding muscle mass loss and
improved functionality.
During the period that these patients are restricted to bed,
muscle fibre transformation to type II occurs, including
reduced oxidative capacity, mitochondrial density and blood
capillaries. In addition, the cardiovascular performance is
reduced due to lower systolic ejection volume and increased
HR. Venous stasis occurs due to reduced activity of the muscle
pump in the limbs and an increased risk of developing throm-
bosis. The period of immobility can also contribute to bone
demineralization and sodium and body water reduction (8).
In the present study, the values described in Table 1
show that no differences were found in the demographic
and clinical characteristics of the patients in both groups,
which demonstrates the homogeneity between groups for all
evaluated parameters. These partial results of homogeneity
between the groups are important because they do not
expose any group to a greater risk factor for its clinical con-
dition commitment. Muscle dysfunction in critical patients is
a common clinical condition in patients submitted to pro-
longed MV periods and hospitalization in intensive care. The
magnitude of muscle weakness in the ICU is extremely
variable and presents an intimate association with perma-
nence time in bed and exposure to risk factors, such as
nutritional condition and MV dependence (4,9).
Critical patients are vulnerable to synthesizing oxidative
agents and reducing antioxidants. Oxidative stress increases
oxidation and has an important role in the pathophysiological
Figure 1 - Illustration of passive cycle ergometer application on
lower limbs in critical patients under mechanical ventilation.
145
CLINICS 2017;72(3):143-149 Oxidative stress and the immune system
de Franc¸a EET et al.
process of muscular dysfunction. Reactive oxygen species (ROS)
provide lipid peroxidation, leading to toxin release and arachi-
donic acid derivatives that damage cell membranes, inactivat-
ing the receptor membrane enzymes and ionic chemistry
response changes. In myocytes, this process of degradation
can be modified by numerous intracellular signals observed
in vitro, including the activation of nuclear factor kappa-b
(NF-k b) (10). Products of cell destruction by ROS produce a
positive feedback, generating more ROS. Simultaneously, the
interaction between ROS with cytokines and other inter-
cellular molecules is associated with muscle degradation.
Figures 3a and 3b show that for both stimulated mono-
cytes (C+) and unstimulated monocytes (C-), there was a
reduction in NO values in the cycle ergometer passive group
compared to those in the control group. NO values decreased
before compared with after the intervention, a phenomenon
not observed in the control group.
These findings suggest a potential beneficial effect of pas-
sive cycle ergometry in oxidative stress reduction in critical
patients; it can be considered a moderate-intensity physical
activity for this type of patient, providing a positive change
in the redox status of cells and tissues from basal levels,
decreasing oxidative damage and increasing resistance to
oxidative stress (11-13). In fact, regular moderate exercise
results in adjustments in antioxidant capacity, which protects
cells against the damaging effects of oxidative stress, pre-
venting subsequent cell damage (14,15).
Our results correlate with the findings of Mercken et al. (16),
who assessed the different intensities of exercise and its effects
on oxidative stress, immediately after and 4 hours after the
cycle ergometer test with 60% workload, in patients with
chronic obstructive pulmonary disease (COPD). There was a
reduction of the induction of systemic oxidative stress trig-
gered by exercise, particularly after submaximal exercises.
Similar to oxidative stress, some selected cytokines also
influence muscle degradation and dysfunction in critical
patients. In a model to explain cachexia, Reid and Li (17)
suggested that the interaction between ROS and proinflam-
matory cytokines such as TNF-a are synergistic, perhaps
indicative of a pathological positive feedback cycle, which is
lower in the regulation of repairing damaged muscle tissue.
Thus, it is not only the direct suppression of muscle activity
that leads to dysfunction in the presence of TNF-a, but a
decrease in repairing and/or an increase of apoptosis that
Figure 2 - Flowchart of the patients who participated in the study.
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results in muscle weakening of these mediated inflammatory
cytokines.
Table 2 shows that there was no significant difference
between the values of TNF-a, IFN-g, IL-6 and IL-10 com-
pared to the moments before and after the cycle ergometer
intervention. Comparing the cycle ergometer and control
groups demonstrated that the passive cycle ergometer in this
study was not enough to promote changes in the immune
system after 1 hour of passive exercise. The level of exercise
intensity and the kinetics of cytokines may have been
responsible for the lack of changes in serum levels of these
cytokines in the studied groups.
According to Winkelman et al. (18), in healthy individuals,
increased TNF-a varies in response to exercise; it is greater
when oxidative stress is present during the exercise. Serum
levels of TNF-a also reduce antioxidant levels in some
skeletal muscles. Because TNF-a is a proinflammatory cyto-
kine, it stimulates the synthesis of several factors, including
adhesion molecules, and ROS.
Another very important cytokine in the inflammatory
process is IL-6, which has a wide range of biological
activities. It is synthesized by the immune system and
skeletal muscle cells, adipocytes, endothelial cells and
intestinal epithelium cells (19). Similar to TNF-a, IL-6 is
released early in the inflammatory cascade. Unlike TNF-a,
IL-6 increases in myosin and appears to have a role in the
maintenance of the power supply during the lifetime of
the myocyte.
Table 1 - Comparison of demographic and clinical variables between the two groups.
Demographic and clinical variables Control (n=10) Passive cycle ergometer (n=9) p * value
Age (years) 56.0 (44.0 – 70.5) 77.0 (32.5 – 81.0) 0.35
Height (cm) 164.5 (157.5 -172.0) 160.0 (153.5 – 162.5) 0.09
Weight (Kg) 67.5 (60.0 -80.0) 70.0 (55.0 – 80.0) 0.84
BMI (Kg/cm2) 25.1 (23.9 – 26.1) 27.3 (22.1 – 33.1) 0.40
APACHE II 23.0 (19.0 – 27.0) 25.0 (15.5 -29.5) 0.90
WB-12:00 am (ml) 1131.0 (200.5 – 1811.0) 487.0 (343.0 – 1341.0) 0.60
MV T (days) 4.0 (2.5 – 8.0) 5.0 (4.0 – 8.0) 0.11
ICU T (days) 4.0 (2.5 – 8.0) 6.0 (5.0 -8.0) 0.06
HGT 130.5 (92.5 – 176.5) 122.0 (88.0 – 177.5) 0.06
Cst (ml/cm H2O) 32.2 (27.1 – 37.1) 27.0 (17.6 – 33.9) 0.15
Rsr (cm H2O/L/s) 12.0 (9.2 – 18.0) 10.0 (10.0 – 16.0) 0.66
FC (bpm) 83.0 (61.0 – 99.0) 86.0 (78.5 – 94.5) 0.60
SpO2 (%) 98.5 (94.0 – 99.5) 98.0 (97.5 – 99.0) 0.71
SBP (mm Hg) 137.5 (108.5 – 162.5) 142.0 (125.0 – 151.0) 0.71
DBP (mm Hg) 80.0 (62.0 – 93.0) 74.0 (66.0 – 88.5) 0.84
Temperature (0C) 36.0 (36.0 - 36.5) 36.5 (36.5 – 37.0) 0.21
ICU mortality 6 (60.0) 7 (77.7) 0.63
Primary reason for admission
Respiratory problem 4 (40.0) 4 (44.4)
Cardiac problem 2 (20.0) 2 (22.2) –
Sepsis/infection 1 (10.0) 2 (22.2)
Other 3 (30.0) 1 (11.1)
Comorbid conditions
Respiratory 2 (20.0) 1 (11.1)
Cardiac 2 (20.0) 3 (33.3)
Endocrine 2 (20.0) 1 (11.1) –
Urinary 1 (10.0) 1 (11.1)
Chronic renal failure 3 (30.0) 2 (22.2)
Sepsis/infection 1 (10.0) 1 (11.1)
Data are the median (25 -75% percentile) before testing.
*Mann-Whitney test and Fisher’s exact test.
Body mass index (BMI); Acute Physiology and Chronic Health Evaluation (APACHE II); water balance in the last 24 hours (WB-24 h); mechanical ventilation
time (MV T); intensive care unit time (ICU T); hemoglucotest (HGT); static compliance of the respiratory system (Cst); resistance of the respiratory system
(Rsr); heart rate (HR); peripheral oxygen saturation (SpO2); systolic blood pressure (SBP); diastolic blood pressure (DBP); temperature and intensive care
unit (ICU) mortality.
Figure 3a and 3b - Variation in the nitric oxide (NO) values in stimulated control positive cell (C+) and unstimulated in the two groups
studied: control and passive cycle ergometer. * Mann-Whitney Test. Differences between the control group and cycle ergometer
3a. (*p=0.0021) and 3b. (*p=0.0076).
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Muscle contraction induces IL-6 production and release to
the plasma in large quantities. An increase of up to 100 times
the initial value can be found in some studies in humans.
The synthesis of IL-6 during exercise is independent of the
production of TNF-a. During exercise, even low intensity,
IL-6 is also synthesized and put into circulation by the
muscle-tendon and fatty tissues (20).
Apart from its proinflammatory properties, high levels
of IL-6 act to stimulate the emergence of antiinflammatory
cytokines in the plasma, including IL-10 and IL-1R a. IL-6
derived from muscles reduces the production of TNF-a,
interrupting the muscle degradation through the destruction
of myosin (18).
The abolition of proinflammatory cytokines such as IL-6,
particularly the powerful IL-b 1 and TNF-a, can benefit the
critically ill. IL-10 is an anti-inflammatory cytokine that is
initially identified by its ability to interrupt the production of
cytokines by T cells. Investigations have shown that IL-10
inhibits the synthesis of IL-1 b, IL-6, TNF-a, reactive oxygen
intermediates and other proinflammatory factors, suppres-
sing various immune responses through individual actions
on multiple cell types.
After exercise, high circulating IL-6 levels are followed by
increased production of IL-10. Studies suggest that exercise
has an antiinflammatory action by inducing IL-10 and IL-6
and inhibiting TNF-a and IL-b 1. The cellular messengers
IL-6 and IL-10 are involved in the maintenance of muscle
function during stretching and some exercise types. Exercise
is used as an inflammation regulator and muscle function
(18). The truth is that important clinical implications have
been demonstrated with physical exercise and neuromuscular
electrical stimulation (NMES) as some of the main prevention
factors in the muscle function of critical patients.
Although changes in inflammatory cytokines in a single
session using the cycle ergometer were observed, we believe
that the implementation of the passive cycle ergometer has
beneficial effects on this response, similar to a report by
Karavidas et al. (21) who studied the application of six weeks
of NMES in the lower limbs of patients with severe heart
disease. They observed that NMES could promote a direct
effect on endothelial function and the peripheral markers of
antiinflammatory activation with reduced levels of TNF-a
and IL-6 and improved blood flow in the brachial artery
observed by ultrasound with doppler. These cytokines may
systemically act as anabolic muscle and enhance stimulus
catabolic effects of critical illness and paralysis. NMES and
exercise can also activate a bioenergetics pathway that
systemically improves the mitochondrial function of skeletal
muscles.
In another study evaluating the effects on the immune
system, after a total of 20 sessions, Akar Olcay et al. (22)
studied patients with COPD under MV whose objective was
to investigate the effect of active mobilization and NMES in
the weaning process, discharge and inflammatory mediators.
A total of 30 patients were divided into three groups with
10 patients in each group: group 1 was submitted to active
mobilization of extremities and NMES, group 2 was sub-
mitted to NMES, and group 3 only underwent active mobili-
zation of extremities. Significant improvement was observed
in peripheral muscle strength, particularly of the lower
extremities, in the groups that performed NMES and
exercises and NMES exclusively. In addition, a reduction of IL-6
and IL-8 in patients submitted to NMES was observed.
It is too early to draw any firm conclusions from our find-
ings. However, we can conclude that passive cycle ergometry
on the lower limbs was enough to reduce NO levels in
cells compared to the control group, showing the benefits of
passive exercise on oxidative stress reduction in the study
population. Regarding the behaviour of the inflammatory
cytokines evaluated in this study, we observed that the use of
the passive cycle ergometer did not cause changes in the
immune system. However, additional research in a larger
population is necessary for more conclusive results.
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